General
PPI Makers Deny Allegations in Master Complaint
Manufacturers of Proton Pump Inhibitors (PPIs) used in the treatment of heartburn have denied all allegations of liability, failure to warn, negligence and breach of warranty, among other claims raised in the “Master Complaint”.
Defendants…
A 2015 Dismissed Mesothelioma Case Reopens
A decision to reopen a mesothelioma case, dismissed in 2015, was taken by the Appellate Division of the Superior Court of New Jersey based on the discovery of a pre-1980 sample of Scotts Turf Builder, allegedly identified as the source of the…
Four Taxotere Lawsuits Selected For 2nd Round of Discovery
With the Taxotere MDL proceedings moving forward, a case management order (PDF) was issued on March 9, wherein Judge Engelhardt…
Atrium Mesh Lawsuits: Monthly Status Conference on March 8
The Atrium C-Qur Hernia Mesh lawsuits centralized in 2017 under MDL 2753 in the U.S. District Court for the District of New Hampshire include all types of C-Qur…
Pa. Xarelto Plaintiffs Request to Amend Master Complaint
More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner …
PPI Cases To Proceed as Per The New Deadlines Ordered
Going forward, Proton Pump Inhibitor (PPI) cases will follow a number of new deadlines ordered by the federal court post the 5th Case Management Conference scheduled this November. Nearly 300 PPI cases are filed in the District of New Jersey by…
A 2015 Risperdal Defense Verdict Reversed
The Superior Court of Pennsylvania reversed a 2015 defense verdict awarded to Janssen Pharmaceuticals by the Philadelphia County Court of Common Pleas on account of insufficient evidence that Risperdal was the cause of…
Ethicon Faces Defective Design Lawsuit For Its Hernia Mesh
A case was filed recently in the U.S. District Court for the Eastern District of Texas by a woman who claims she suffered complications following a laparoscopic hernia repair. In this case, allegations are against Ethicon Physiomesh Composite…
A second loss for AbbVie's AndroGel, slammed with $140 Million
AbbVie faced a second loss in the Testosterone Replacement Therapy (TRT) bellwether trial when the jury announced a verdict of nearly $140 million in favor of the plaintiff. The…
JPML Denies To Vacate Conditional Transfer of Taxotere Cases
The request to vacate the conditional transfer of one Taxotere lawsuit was denied by the JPML panel on the grounds that the transfer would further expedite the litigation process as a whole. The case was…